Immune status following alemtuzumab treatment in human CD52 transgenic mice

Autor: Turner, Michael J., LaMorte, Michael J., Chretien, Nathalie, Havari, Evis, Roberts, Bruce L., Kaplan, Johanne M., Siders, William M.
Zdroj: In Journal of Neuroimmunology 15 August 2013 261(1-2):29-36
Databáze: ScienceDirect